stockrowTarsus Pharmaceuticals, Inc. (TARS) vs Viridian Therapeutics, Inc. (VRDN)
- Tarsus Pharmaceuticals, Inc. TARS 67.52 0.00%
- Viridian Therapeutics, Inc. VRDN 28.83 +0.98%
Tarsus Pharmaceuticals, Inc. and Viridian Therapeutics, Inc. are both Biotechnology companies. Tarsus Pharmaceuticals, Inc. and Viridian Therapeutics, Inc. are of similar size ($3.3B and $3.2B). Tarsus Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 86.3% against −62.8%. Tarsus Pharmaceuticals, Inc. has the higher net margin (−102.9% vs −1,724.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Tarsus Pharmaceuticals, Inc. leads on 8 and Viridian Therapeutics, Inc. on 8.
Valuation
Profitability
| Metric | TARS | VRDN | Biotechnology median |
|---|---|---|---|
| Gross margin | 93.21% | 100.00% | 65.16% |
| Operating margin | (102.04%) | (1,781.38%) | 0.00% |
| Net margin | (102.93%) | (1,724.06%) | 0.00% |
| Free cash flow margin | 4.76% | (1,305.42%) | 0.00% |
| Return on equity | (319.84%) | 0.00% | (50.12%) |
| Return on assets | (135.04%) | (56.49%) | (45.60%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack